U.S. Food and Drug Administration (FDA) Approves Omeros' New Drug Yartemlea for the Treatment of Transplant Complication TA-TMA
Wedoany.com Report-Dec.31, The U.S. Food and Drug Administration (FDA) has officially approved Yarte...
Mabwell's Adalimumab Injection Approved for Marketing in Indonesia
Wedoany.com Report-Dec.31, Mabwell (688062.SH), an innovative biopharmaceutical company with a full ...
Osaikang Pharma and Adlai Nortye Enter into License Agreement for Type 1 Innovative Drug AN9025 Project
Wedoany.com Report-Dec.30, Osaikang announced that its subsidiary Jiangsu Osaikang Pharmaceutical Co...
Ipsen Outlays $1BN for China-Based Simcere’s Preclinical ADC
Wedoany.com Report-Dec.28, Ipsen has entered into an exclusive licensing agreement with Simcere Zaim...
China’s Jacobio Inks Immuno-Oncology Deal Worth $1.9 B With AstraZeneca
Wedoany.com Report-Dec.26, China-based Jacobio Pharma (1167.HK) has entered into a global exclusive ...
Asahi Kasei Pharma to Relocate Global R&D Hub to Shonan Ipark in Japan
Wedoany.com Report-Dec.26, Asahi Kasei Pharma Corporation has announced plans to relocate its R&...
US FDA Approves Omeros’ Drug to Treat Dangerous Transplant Complication
Wedoany.com Report-Dec.25, Omeros Corporation announced on Wednesday that the U.S. Food and Drug Adm...
Sanofi Pushes Ahead on Adult Vaccines With $2.2 Billion Dynavax Deal
Wedoany.com Report-Dec.25, Sanofi announced on Wednesday, December 24, 2025, that it has entered int...
Agios Pharma Shares Jump as US FDA Expands Approval for Blood Disorder Drug
Wedoany.com Report-Dec.25, Agios Pharmaceuticals announced late on Tuesday that the U.S. Food and Dr...
Sinocare Receives Medical Device Registration Certificates for Multiple Products
Sinocare announced on December 23 that its Blood Glucose, Uric Acid, and Blood Ketone Analyzer, Bloo...
京公网安备 11010802046720号